1.
Transfus Clin Biol
; 29(1): 92-93, 2022 Feb.
Artículo
en Inglés
| MEDLINE
| ID: mdl-34391927
RESUMEN
India has literally been devastated by the second wave of the Covid-19. Convalescent plasma (CP) therapy which was approved initially for Covid-19 in India has been recently excluded from the Covid-19 management protocol. Herein we would like to explore the major challenges for CP therapy in India that we observed during the current pandemic.